Logo image of KYTX

KYVERNA THERAPEUTICS INC (KYTX) Stock Analyst Ratings

NASDAQ:KYTX - Nasdaq - US5019761049 - Common Stock - Currency: USD

2.78  -0.06 (-2.11%)

After market: 2.8 +0.02 (+0.72%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to KYTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 26.72. This target is 861.29% above the current price.
KYTX was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about KYTX.
In the previous month the buy percentage consensus was at a similar level.
KYTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

KYTX Historical Analyst RatingsKYTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.786.0624.4826.7250.40 - 117.99% 780.58% 861.29% 1,712.95%

Related screens

KYTX Current Analyst RatingKYTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2024-11-20 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-11-15 Wells Fargo Maintains Overweight -> Overweight
2024-10-10 UBS Initiate Buy
2024-09-19 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-15 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-07-31 JP Morgan Maintains Overweight -> Overweight
2024-07-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-07-03 HC Wainwright & Co. Initiate Neutral
2024-03-04 JP Morgan Initiate Overweight
2024-03-04 Morgan Stanley Initiate Overweight